Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC
Clinical trial NCT02492568 · COMPLETED
Trial details
- NCT number
- NCT02492568
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-06-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.